About Cirrus Therapeutics
Cirrus Therapeutics is a private company based in Cambridge, Massachusetts, incorporated in 2022 in Delaware. It has reported $6,698,321 raised in one offering on Form D since August 2025.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 4, 2025 | Aug 19, 2025 | $6,698,321of $15.6M target | 8 | $837K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Cirrus Therapeutics's Form D filed Aug 19, 2025.
Alexandra Cantley
Director
Also a director at Auron Therapeutics, Crossbow Therapeutics and EpiBiologics.
AD
Andrew Dick
Director and promoter
KS
Khoo Shih
Director
YC
Ying Kai Chan
President and director